For Immediate Release
March 3, 2016
Loki Fish Company of Seattle, WA is voluntarily recalling two lots of Wild Smoked Pink Salmon Portions, due to a positive test result for Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, listeria infection can cause miscarriages and stillbirths among pregnant women.
The affected Wild Smoked Pink Salmon Portions comes in a 4-7 ounce, clear plastic package. The lot 121215 5594 or 121215 5613 is found on the back of the package.
Product was distributed to retail stores in Oregon and Washington, via mail order, and sold at Seattle area farmers markets. For a list of retail outlets and farmers markets that may have carried the identified product, and for other updates, please go to www.lokifish.com.
No illnesses have been reported to date in connection with Loki Fish Company product. The product is processed by Felix Custom Smoking, a Loki Fish Company co-packing vendor.
The retail sample was collected during routine sampling activities conducted by Washington State Department of Agriculture (WSDA) and presence of Listeria monocytogenes was confirmed. This recall is being made with the knowledge of the U.S. Food and Drug Administration and WSDA.
Consumers who have purchased the identified product are urged not to consume and return it to the place of purchase for a full refund. In addition to the Loki Fish Company website, consumers may contact the company directly with questions at 206-937-1048 between Monday-Friday, 9am-4pm PST.
“As a family owned fishing business that direct markets our catch, nothing is more important to us than the safety of the products we sell,” said Loki Fish Company General Manager, Dylan Knutson. Knutson continued, “We have ordered additional tests to make sure we isolate the contamination and fully understand its cause. As soon as we have additional information, we will share it with the public as well as with the FDA and WSDA.”